FENC Fennec Pharmaceuticals, Inc.

Fennec Pharmaceuticals Inc is a clinical-stage biotechnology company. It is primarily engaged in research and development activities.

As of 12/03/2021     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  Canada
IPO date:  09/09/2014
Outstanding shares:  26,010,186
Average volume:  302,179
Market cap:   $110,543,291
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    31447P100
ISIN:        CA31447P1009
Valuation   (See tab for details)
PE ratio:   -35.59
PB ratio:   6.06
PS ratio:   650.25
Return on equity:   -68.04%
Net income %:   -7,610.06%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy